Using human pluripotent stem cells and DNA-cutting protein from meningitis bacteria, researchers from the Morgridge Institute for Research and Northwestern University have created an efficient way to target and repair defective genes.
Writing today (Monday, Aug. 12, 2013) in the Proceedings of the National Academy of Sciences, the team reports that the novel technique is much simpler than previous methods and establishes the groundwork for major advances in regenerative medicine, drug screening and biomedical research.
Zhonggang Hou of the Morgridge Institute’s regenerative biology team and Yan Zhang of Northwestern University served as first authors on the study; James Thomson, director of regenerative biology at the Morgridge Institute, and Erik Sontheimer, professor of molecular biosciences at Northwestern University, served as principal investigators.
“With this system, there is the potential to repair any genetic defect, including those responsible for some forms of breast cancer, Parkinson’s and other diseases,” Hou said. “The fact that it can be applied to human pluripotent stem cells opens the door for meaningful therapeutic applications.”
Zhang said the Northwestern University team focused on Neisseria meningitidis bacteria because it is a good source of the Cas9 protein needed for precisely cleaving damaged sections of DNA.
“We are able to guide this protein with different types of small RNA molecules, allowing us to carefully remove, replace or correct problem genes,” Zhang said. “This represents a step forward from other recent technologies built upon proteins such as zinc finger nucleases and TALENs.”
These previous gene correction methods required engineered proteins to help with the cutting. Hou said scientists can synthesize RNA for the new process in as little as one to three days – compared with the weeks or months needed to engineer suitable proteins.
The Latest on: Regenerative medicine
- AVITA Medical Announces Receipt of A$1.4 Million Research and Development Tax Credit on December 17, 2018 at 7:49 pm
AVITA Medical (ASX: AVH, OTCQX: AVMXY), a global regenerative medicine company, today announced that it has received a Research and Development Tax Incentive cash rebate from the Australian Tax Office ... […]
- New regenerative medicine treatments provide relief for back/neck pain patients on December 17, 2018 at 1:10 pm
CINCINNATI, OH (FOX19) -Terri is a jovial 48-year-old who loves serving people and making them happy. When she started having neck pain after standing for more than a half hour or so, she was afraid o... […]
- $5.66 million CIRM grant strengthens researchers' spina bifida work on December 17, 2018 at 11:21 am
UC Davis researchers have received a $5.66 million grant from the California Institute for Regenerative Medicine (CIRM) supporting their research on stem-cell therapies for spina bifida. Professor Aij... […]
- Researchers develop first ever model for patient-specific treatment of appendix cancer on December 17, 2018 at 8:29 am
WINSTON-SALEM, N.C. - DEC. 17, 2018 - Scientists at the Wake Forest Institute for Regenerative Medicine (WFIRM) have recently developed a process that may change the way cancer of the appendix is trea... […]
- Growing a brain: Two-step control mechanism identified in mouse stem cells on December 17, 2018 at 8:04 am
This fundamental research using mice may inform regenerative medicine treatments for neurodegenerative diseases and spinal cord injuries, in the future. When an embryo develops, stem cells ... […]
- Regenerative Medicine Foundation Announces 2019 “Stem Cell and Regenerative Medicine Action Award” Honorees on December 14, 2018 at 9:14 am
Awards to be presented at Gala Dinner at the 14th World Stem Cell Summit in Miami, January 23, 2019#WSCS2019 MIAMI, FL, Dec. 14, 2018 (GLOBE NEWSWIRE) — Five remarkable bridge-building ... […]
- Regenerative Medicine market growth rate, revenue, manufacturers, customer needs and forecast to 2025 on December 12, 2018 at 12:38 pm
The newest research report global Regenerative Medicine Market illustrates pin point sharp market insights includes detailed Regenerative Medicine industry aspects forecast over a period from 2018 to ... […]
- Innovations in Stem Cells for Regenerative Medicine on December 11, 2018 at 11:33 am
Q: What are some of the main challenges when working with and differentiating stem cells in the lab and then scaling them for manufacturing purposes? A: I started stem cell work at the University of W... […]
- Dr. Marc Penn to Present on Regenerative Medicine at 26th Annual A4M World Congress on December 13 on December 10, 2018 at 1:02 pm
Dr. Penn will deliver keynote presentation titled "Transforming Regenerative Medicine: Quality, Collaboration, & Data" LAS VEGAS, Dec. 10, 2018 /PRNewswire/ -- The A4M World Congress has announced ... […]
- Regenerative Medicine market illuminated by new report on December 4, 2018 at 9:14 am
Regenerative Medicine Market is expected to reach USD 38.70 Billion by 2021 from USD 13.41 Billion in 2016 at a CAGR of 23.6% from 2016 to 2021. The report provides a detailed overview of the major dr... […]
via Google News and Bing News